Revitalist Enters USD $1B TMS Market

Share Post:

VANCOUVER, BC, October 13, 2021 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the
“Company”) (CSE: CALM) (OTC: RVLWF) is pleased to report that its clinic locations will now work with
psychiatric physicians at each clinic location currently offering transcranial magnetic stimulation
(“TMS”). This extension to its existing TMS service protocol provides access to care for individuals
seeking coverage through their insurance benefits and increases market share for Revitalist.

TMS is a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve
symptoms of those suffering from depression, Alzheimer’s disease, Parkinson’s disease, and Epilepsy.
TMS is typically used when other depression treatments haven’t been effective.


Expert Market Research reports, “the global transcranial magnetic stimulator market attained a value of
around USD 962.5 million in 2020. The industry is further expected to grow in the forecast period of
2021-2026 at a CAGR of 9% to reach USD 1.614 billion by 2026.”


Revitalist CEO, Kathryn Walker reports, “Working with psychiatrists to offer TMS services at Revitalist is
an all-around win. Patients receive access to quality TMS treatment options covered by insurance, the
psychiatric community gains access to practice TMS, and Revitalist unlocks additional revenue
potential.”


Expert Market Research report available here.


ABOUT REVITALIST LIFESTYLE AND WELLNESS
Revitalist Lifestyle and Wellness Ltd. is a publicly traded (CSE: CALM) (OTC: RVLWF) company,
headquartered in Knoxville, Tennessee, with five clinics operating across the United States and
expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being
through a combination of comprehensive care and future-centric treatments provided by medical
professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018,
Revitalist has provided over 7,000 infusions for patients suffering from treatment-resistant conditions.
Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can
bring anyone closer to total wellness.


On Behalf of the Board
Kathryn Walker
Chief Executive Officer


For further information please contact:
Revitalist Lifestyle and Wellness Ltd.
Investor Relations
[email protected]
(865) 585-8414


For additional information and to be added to the Company!s mailing list, please click here.


Forward Looking Statements
This news release contains forward-looking statements and information within the meaning of
applicable securities legislation. Often, but not always, forward-looking statements and
information can be identified by the use of words such as “plans”, “expects” or “does not
expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or
“believes”, or variations of such words and phrases or state that certain actions, events or
results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward
looking statements or information involve known and unknown risks, uncertainties and other
factors which may cause the actual results, performance or achievements of Revitalist to be
materially different from any future results, performance or achievements expressed or implied
by the forward-looking statements or information contained in this news release.
Risks, uncertainties, and other factors involved with forward-looking information could cause
actual events, results, performance, prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information. The Canadian Securities Exchange
has not reviewed and does not accept responsibility for the adequacy or accuracy of the content
of this news release.

Stay Connected

More Press Releases

Psychedelic Community Reacts To FDA Committee’s Critique Of Lykos’ MDMA Studies Guest Column | June 14, 2024 As told to Abby Proch, executive editor of